Consolidated Statements of Convertible Redeemable Preferred Stock and Stockholders’ Equity (Deficit) (Parentheticals) - Total Onconetix Equity (Deficit)	12 Months Ended
Dec. 31, 2022 USD ($)
Issuance of common stock in initial public offering, net	$ 2.9
Issuance of common stock and warrants in April private placement, net	1.1
Issuance of common stock and warrants in August private placement, net	$ 2.2

Issuance of common stock and warrants in April private placement, net.

No definition available.

Name:	onco_IssuanceOfCommonStockAndWarrantsInAprilPrivatePlacementNet
Namespace Prefix:	onco_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration